Literature DB >> 10329749

Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease.

K Ito1, P K Morrish, J S Rakshi, T Uema, J Ashburner, D L Bailey, K J Friston, D J Brooks.   

Abstract

OBJECTIVE: To apply statistical parametric mapping to 18F-dopa PET data sets, to examine the regional distribution of changes in dopaminergic metabolism in early asymmetric Parkinson's disease.
METHODS: Thirteen normal volunteers (age 57.7 (SD 16.5) years; four women, nine men ) and six patients (age 50.3 (SD 13.5) years; three women, three men) with asymmetric (right sided) Parkinson's disease were studied. Images from each dynamic dopa PET dataset were aligned and parametric images of 18F-dopa influx (Ki) were created for each subject. The Ki images were transformed into standard stereotactic space. The Ki values of the caudate and putamen on spatially normalised images were compared with the Ki values before normalisation. The application of statistical parametric mapping (SPM) allowed statistical comparison of regional Ki values on a voxel by voxel basis between healthy volunteers and patients with Parkinson's disease.
RESULTS: There was a strong correlation between the Ki values before and after spatial normalisation (r=0.898, p=0.0001). Significant decreases in the Ki values were found for the Parkinson's desease group throughout the entire left putamen (p< 0.001) and focally in the dorsal right putamen (p<0.001). Decreased Ki values were also shown bilaterally in the substantia nigra (p< 0.01).
CONCLUSION: Using (SPM) and 18F-dopa PET, reductions in both striatal and nigral brain dopaminergic function could be demonstrated in early Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329749      PMCID: PMC1736402          DOI: 10.1136/jnnp.66.6.754

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  Comparing functional (PET) images: the assessment of significant change.

Authors:  K J Friston; C D Frith; P F Liddle; R S Frackowiak
Journal:  J Cereb Blood Flow Metab       Date:  1991-07       Impact factor: 6.200

2.  Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease.

Authors:  P K Morrish; G V Sawle; D J Brooks
Journal:  Brain       Date:  1996-12       Impact factor: 13.501

3.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

Authors:  S J Kish; K Shannak; O Hornykiewicz
Journal:  N Engl J Med       Date:  1988-04-07       Impact factor: 91.245

4.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations.

Authors:  C S Patlak; R G Blasberg
Journal:  J Cereb Blood Flow Metab       Date:  1985-12       Impact factor: 6.200

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  PET studies of parkinsonian patients treated with autologous adrenal implants.

Authors:  M Guttman; R S Burns; W R Martin; R F Peppard; M J Adam; T J Ruth; G Allen; R A Parker; N B Tulipan; D B Calne
Journal:  Can J Neurol Sci       Date:  1989-08       Impact factor: 2.104

7.  The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

Authors:  D J Brooks; E P Salmon; C J Mathias; N Quinn; K L Leenders; R Bannister; C D Marsden; R S Frackowiak
Journal:  Brain       Date:  1990-10       Impact factor: 13.501

Review 8.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

9.  Detection of preclinical Parkinson's disease with PET.

Authors:  D J Brooks
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

10.  The reproducibility of striatal uptake data obtained with positron emission tomography and fluorine-18-L-6-fluorodopa tracer in non-human primates.

Authors:  B D Pate; B J Snow; K A Hewitt; K S Morrison; T J Ruth; D B Calne
Journal:  J Nucl Med       Date:  1991-06       Impact factor: 10.057

View more
  5 in total

Review 1.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

2.  Detection of visual activation in the rat brain using 2-deoxy-2-[(18)F]fluoro-D: -glucose and statistical parametric mapping (SPM).

Authors:  M L Soto-Montenegro; J J Vaquero; J Pascau; J D Gispert; P García-Barreno; M Desco
Journal:  Mol Imaging Biol       Date:  2008-11-27       Impact factor: 3.488

3.  Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging.

Authors:  M Ghaemi; R Hilker; J Rudolf; J Sobesky; W-D Heiss
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

Review 4.  SPECT molecular imaging in Parkinson's disease.

Authors:  Ling Wang; Qi Zhang; Huanbin Li; Hong Zhang
Journal:  J Biomed Biotechnol       Date:  2012-03-24

5.  Comparison of 6-[18F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism.

Authors:  Enrico Michler; Daniel Kaiser; Kiriaki Eleftheriadou; Björn Falkenburger; Jörg Kotzerke; Sebastian Hoberück
Journal:  EJNMMI Res       Date:  2021-02-15       Impact factor: 3.138

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.